Source:http://linkedlifedata.com/resource/pubmed/id/11686915
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2001-11-5
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
1082-720X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
6
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
333-41
|
pubmed:dateRevised |
2008-3-10
|
pubmed:meshHeading |
pubmed-meshheading:11686915-Electrocardiography,
pubmed-meshheading:11686915-Exercise Test,
pubmed-meshheading:11686915-Heart Rate,
pubmed-meshheading:11686915-Humans,
pubmed-meshheading:11686915-Ion Channels,
pubmed-meshheading:11686915-Principal Component Analysis,
pubmed-meshheading:11686915-Societies, Medical,
pubmed-meshheading:11686915-Ventricular Function
|
pubmed:year |
2001
|
pubmed:articleTitle |
ISHNE guidelines for electrocardiographic evaluation of drug-related QT prolongation and other alterations in ventricular repolarization: task force summary. A report of the Task Force of the International Society for Holter and Noninvasive Electrocardiology (ISHNE), Committee on Ventricular Repolarization.
|
pubmed:affiliation |
Heart Research Follow-up Program, Box 653, University of Rochester Medical Center, Rochester, New York 14642, USA. heartajm@heart.rochester.edu
|
pubmed:publicationType |
Journal Article,
Guideline,
Research Support, Non-U.S. Gov't,
Practice Guideline
|